Industry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee

Similar documents
Presentation to Parliamentary Portfolio Committee on Health

Regulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices

STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018

HISTORY, CAPACITY AND POSITION

REGULATORY CHALLENGES IN SOUTH AFRICA

Medical Devices. SOUTH AFRICA Bowman Gilfillan

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

TGA: the current regulatory reform agenda

1. Introduction. 2. Role of PSI as Pharmacy Regulator

MEDICINES CONTROL COUNCIL

KEY DIFFERENCES BETWEEN THE NEW MEDICAL DEVICE AND THE OTC REGULATIONS IN EUROPE

MEDICINES CONTROL COUNCIL

ISO 13485:2016 MEDICAL DEVICES QMS TRANSITION GUIDE

STATUTORY INSTRUMENTS. S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015

COMPLETION OF THE CTD IN APPLICATION FOR A COMPLEMENTARY MEDICINE

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.

BILATERAL SCREENING MEETING

16 February 2009 SUBMISSION BY THE SOUTH AFRICAN MEDICAL DEVICE INDUSTRY ASSOCIATION (SAMED)

REPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD DRAFT GUIDELINE FOR IMPORTATION OF ORPHAN MEDICINAL SUBSTANCES IN KENYA

PROVISIONAL TRANSLATION

B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations

Guide to Interchangeable Medicines

Planning For The FDA s 'Deeming Rule' For E- Cigarettes

MHRA Pharmacovigilance Inspections: Prepare and Manage for Success

Australian Jurisdictional Update September 2018

Recall Guidelines. for Chinese Medicine Products

Guideline on the Regulation of Therapeutic Products in New Zealand

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENERAL FOOD LAW Summary Record of Meeting of 25 June 2007

Guidance for Industry

Barbara Brohl Executive Director & State Licensing Authority Colorado Department of Revenue

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs Hyman, Phelps & McNamara, P.C. Washington, DC

Review of Medicines Act 1968: informal consultation on issues relating to the PLR regime and homeopathy

Quality Management System Certification. Understanding Quality Management System (QMS) certification

EUROPEAN UNION. Brussels, 15 October 2007 (OR. en) 2005/0227 (COD) PE-CONS 3627/07 MI 149 ECO 83 SAN 123 CODEC 621

GUIDE FOR THE NEW ELECTRONIC PAYMENT SYSTEM. Version 1.0 Spanish Agency of Medicines and Medical Devices

A Proposal for a Trans Tasman Agency to Regulate Therapeutic Products

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

Update on Australian regulatory framework for medical devices

Medical Devices Act 1

Medication Disposal in Alameda County and the Safe Medication Disposal Ordinance

Proposed Radiation Safety Regulations: Submission form

PHYSIOTHERAPY ACT AUTHORIZATION REGULATIONS

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Australian regulatory guidelines for medical devices

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No.

Development Bank of Southern Africa Amendment Bill [B ]

Latest Gazetted Regulations and Guidelines : SMASA Concerns/Comments

LEAF Marque Assurance Programme

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations

Overview of the Legal Framework for Medical Device Regulation in the United States

Medical Devices. UKRAINE Magisters

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

IC ARTICLE 20. HEARING AID DEALERS. IC Chapter 1. Regulation of Hearing Aid Dealers; Creation of Advisory Committee; Certificates

New Vaccines in SA. Regulatory Perspectives James Southern 2015

Darwin Marine Supply Base HSEQ Quality Management Plan

Australian regulatory guidelines for medical devices

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

Designing publicly funded healthcare markets Note by the Russian Federation

General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme

Cannabis Legalization and Regulation in British Columbia Discussion Paper

(English text signed by the State President) as amended by

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

Medical Devices - Reporting to MHRA.. Emma Rooke, December 2015

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Understanding the New Access to Cannabis for Medical Purposes Regulations

Cannabis Legalization Proposed Bylaws

Malaysia s Experience in Regulating the Medical Device Sector

Alberta - US Comparator: Standard-Making and Enforcement Functions

The Nutrition (Amendment) (EU Exit) Regulations 2018

DIRECTIVES. (Text with EEA relevance)

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES

Update on WHO Prequalification of In Vitro Diagnostics

Alignment of FSMA with Existing Food Safety Programs International Citrus & Beverage Conference

ISO 13485:2016 Medical Devices Training Handbook

Canadian Grain Commission

TRAUMA RECOVERY/HAP OPERATING GUIDELINES

Guidance for Municipalities Regarding Marijuana for Adult Use January 2018

XOSERVE LIMITED SERVICES SCHEDULE FOR THE PROVISION OF NON-CODE USER PAYS SERVICES (REFERENCE NUMBER XNCUP(SS)06) DATED 20 INTRODUCTION

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

REGULATORY ENVIRONMENT FOR MEDICAL DEVICES IN NEW ZEALAND

Guidance on Medical Devises Bundling / Grouping Criteria MDS-G7 MDS G7. Guidance on Medical Devices Bundling/ Grouping Criteria

Explanatory Memorandum to accompany the following subordinate legislation-

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use

Guidelines for Product Recall or Withdrawal

How to change the legal classification of a medicine in New Zealand

on the advertising of medicinal products for human use

Workshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation

a practical guide ISO 13485:2016 Medical devices Advice from ISO/TC 210

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

Legalization of Cannabis- Overview

Act 443 of 2009 House Bill 1379

Medical - Combined Medical Devices Guideline

RE: CONSULTATION ON DRAFT - DRUG AND NATURAL HEALTH PRODUCTS RECALL GUIDE

ACS Submission: Consultation on the advertising of electronic cigarettes

Committed to Environment, Health, & Safety

Lakshy Management Consultant Pvt. Ltd.

Transcription:

Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee

Today s Topics: 1. Medical Device Definition - Differences 2. Status of Medical Device Regulations in South Africa 3. Industry Perspective 4. Industry Concerns 5. Implementation Proposals 6. The Act and Amendments (Draft Bill 6 Overview) 7. Draft Bill 6 of 2014 Current Status 8. Draft Medical Device Regulations 9. Draft Medical Device Guidelines

Definition of a Medical Device any instrument, apparatus, appliance, material or any other article, whether used alone or in combination, including the software necessary for its proper application intended by the manufacturer to be used on human beings for the purpose of: diagnosis, prevention, monitoring, treatment or alleviation of disease, or compensation for an injury or handicap, Investigation, replacement or modification of the anatomy or of a physiological process, control of conception and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function *electrometrical by such devices means are regulated by the Department of Radiation Control

Medicines and Medical Devices Differ MEDICINES Discovered Stable formulation developed Highly mechanised manufacture Consumed by use Systemic toxicity Large populations of exposure High % of self administration Patient may choose to stop use Use Medical Devices for administration (Needles & Syringes or Asthma pump) MEDICAL DEVICES Designed Constant improvements or changes Often manufactured by hand operations Available for study after use Adverse events most often local in nature Relatively limited populations of exposure Mostly intended for professional use Self use mostly intended for monitoring

Medical Devices Examples *electrometrical devices are regulated by the Department of Radiation Control

Medical Device Regulations Status: As of 09 Oct 2014, medical devices and in-vitrodiagnostics remain unregulated in South Africa* Bill 6 the legislation that will empower NDoH to regulate medical devices, through the creation of the South African Health Products Regulatory Authority, required amendments Bill 6 of 2014 was Gazetted in February 2014 to introduce amendments. The NDoH issued Draft Regulations for Medical Devices for public comment on 22 April 2014 The NDoH issued Draft Guidelines for Medical Device for public comment on September 2014 *electrometrical devices are regulated by the Department of Radiation Control

Industry Perspective Industry welcomes the Department of Health s regulatory framework, drafted in the interests of safety for South African patients and users of medical devices SAMED appreciates the DoH s recognition of international approaches to regulating medical devices SAMED appreciates the DoH s recognition of other Regulatory Authorities SAMED appreciates other initiatives taken by the DoH in preparation for Medical Device regulation (Regulatory Institute) SAMED requests the DoH to recognise and engage with associations representing the Medical Devices Industry SAMED requests the DoH to pronounce on removal process requirements for Combination MD s currently registered as Medicines SAMED recommends a phased Risk Based approach to Medical Device regulations that will not be disruptive to continued provision of MD s

Industry Concerns Legal Framework is Medicine focused Cannot Regulate by Guidelines. Contradictions Act /Regs. / Guidelines Transition and Capacity Building Appropriate & Adequate Staff Roles of CEO, Board Members vs Registrar (Cater for Registrars) Inclusion of Pricing Considerations in Regulations (Stand Alone) Local Manufacturers International STD s compliance costly. Quote international STD s (SANS STD s?). Requirements for scheduled substances in combination MD Record keeping for Prescriptions in Combination MD s? Local labelling requirements of MD s with scheduled substanceswarnings, precautions, limitations, incompatibilities SAMED none recognition by regulator (Lack of response) Implementation Road Map (Timelines) Consideration of other Acts Affecting Industry

Implementation Proposals Redraft of amendments to Enabling Act Amendments to Draft Regulations, must be Medical Device Specific Removal of Combination Medical Devices currently in Medicine register Stakeholder Engagement Communication with Industry Association Prepare for the Regulatory / Registration Requirements Capacity Building Staff and IT Website Further discussions required

Alignment & Engagement ENABLING ACT Medicine Focused Need to allow for Medical Device Specific Sections / Clauses Specific Sections for MD Further Discussions Parliamentary Portfolio REGULATIONS Not Device Specific Scheduled Substances in MD Medicines Pharmacist / Medicines Controls? Further Discussions Workshop GUIDELINES Welcome as MD tailored & harmonised. Comments Open. Timelines Critical Global Aware e.g. Trials Further Discussions Workshop

Phased Approach Non Disruptive PREMARKET PRODUCT MANUFACTURERS PLACING IN MARKET SALE VENDOR Supply Chain Licences New Product Registrations START HERE POST MARKET AFTER SALE / USE VENDOR / USER Listing of Vendors Listing of Products Removal process of Combination MD currently registered as Medicines Users (Other Acts)

Implementation Proposals Estimated Timelines START HERE PREMARKET Capacity Building of Various Stakeholders Local Manufacturers Capacity Building SAHPRA Conformity Assessments Licencing of Manufacturers Licencing of Vendors PLACING IN MARKET Phased Approach Licencing of Vendors (QMS) Listing of Exempt Class / MD Product Listed with RA Call Up Risk Based Registration of MD - recognition of other RA POST MARKET ROLES OF VARIOUS STAKE HOLDERS ~ Adverse Event Reporting ~ Complaint Management ~ Vigilance Reporting -RA ~ Field Action Notifications -RA ~ Service & Maintenance ~ CAPA

MEDICINES AND RELATED SUBSTANCES AMENDMENT BILL Government Gazette #37361 of 20 Feb 2014 To amend the Medicines and Related Substances Act, 1965

Draft Bill 6 of 2014: Overview PRINCIPAL ACT 101 of 1965 Medicines & Related Substances MEDICINE FOCUSED MANY AMENDMENTS SINCE 1965 MANY REGULATIONS UNDER THIS ACT AMENDMENT Act 72 of 2008 DRAFT BILL SIGNED INTO LAW NOT TAKEN INTO EFFECT MAJOR AMENDMENTS INCLUSION OF MEDICAL DEVICES / IVD s FURTHER AMENDMENTS DRAFT BILL MARCH 2012 3 MONTHS PUBLIC COMMENT AMENDMENTS NOT OPERATING FURTHER AMENDMENTS DRAFT BILL PUBLISHED 2014

Draft Bill 6 of 2014: Overview Seeks to Establish / Provides For: A New Regulatory Authority ( SAHPRA ) Operational Functioning as a Public Enterprise The Appointment of a Chief Executive Officer. Additional Definitions Transitional Arrangements MCC SAHPRA

Draft Bill 6: Reasons for Amendments 1. to define certain expressions 2. to delete or amend certain definitions 3. to provide for the objects and functions of the SAHPRA 4. to provide for the composition, appointment of chairperson, vice-chairperson and members, disqualification of members, meetings and committees of the Board of the Authority

Draft Bill 6: Reasons for Amendments 5. to replace the word products with the word medicines and the expression scheduled substances in order to correctly reflect the subject matter of the said Act 6. to effect certain technical corrections 7. to provide for matters connected therewith

Draft Bill 6 of 2014: Current Status Portfolio Committee Public hearings set for Oct/Nov 2014

Draft Bill 6 of 2014: SAMED Actions Preparing to present and to submit to the Parliamentary Portfolio Committee on health. Separation of Sections / Clauses not applicable to Medical Devices, where applicable. Propose changes for technical correctness that will allow legal enforcement. Harmonization (In draft guidelines, not in Draft Regulations or Bill). Proposals must align. Allow for Registrars, other procedures and functions Combination Devices

Draft Medical Device Regulations Define which, how Medical Devices will be regulated and includes in-vitro Diagnostics Requires licencing and registration of MD companies and products Makes provisions for combination MD s, custom-made, implantable Divides devices into Risk Classes A, B C, D Requires adverse event reporting Regulates labelling, IFU s, Regulates clinical trials Advertising Transitional Measures and implementation Penalties for non-compliance Follows the format of medicines

Combination Medical Devices Requirements, where applicable: Registered Pharmacist? Approved name, schedule of therapeutic substance Schedule 2 and above has restricted advertising Schedule 5-8 registers requires reporting and record keeping Record keeping for Prescriptions? Labelling requirements -warnings, precautions, limitations, incompatibilities Control of Scheduled substances within a Medical Device Medicines Controls. Control Supply Chain Medical devices should not be registered as medicines - Lack of data medicine registration, incompatible dossier - 5 year lead time

Medical Devices are not Free for all users Medical device? 22

How to comply with requirements? Licenceto import manufacture distribute Validfor 5 years Authorised Representative Good Manufacturing/ Distribution Practice REGULATION 8: LICENCE Quality Manual to demonstrate safety, quality and performance Notify Regulator of any changes Qualified Staff Pass Site Inspection (if required) Demonstrate ability to track and trace MD s Pay Fees

How to comply with requirements? Details of: Applicant Holder of Certificate of Registration Responsible Person Screening Form Manufacturer Details Site Master File Clinical Investigation Sites Register eachmedical device OR group Or family REGULATION 11: REGISTRATION GMP certificate from Regulator of Country of Origin Conformity Assessment Certificate Site Master File International Registration Certificates Conditions of Registration Medical Device Details: Name, Model Intended Purpose Country of Origin International Registrations Risk Classification GMDN Code Label Package Insert Instructions for use Evidence of conformity to the Essential Principles for Safety and Performance Pay Fees

Draft Medical Device Guidelines Published for comment on 26 September 2014 Welcome by Industry Device orientated Recognition of IMDRF Harmonisation Recognition of other Regulatory Authorities provision Recognise differences between Medicines & Medical Devices Medical Device Specific with Local Specific Requirements Labelling Requirements for Combination Devices Scheduled Substance limitations and incompatibilities. Comment Phase open Errors in standards Timelines needed Grandfathering / Sun setting? Bill 6 Regulations Guidelines

Industry Perspective Industry welcomes the Department of Health s regulatory framework, drafted in the interests of safety for South African patients and users of medical devices SAMED appreciates the DoH s recognition of international approaches to regulating medical devices SAMED appreciates the DoH s recognition of other Regulatory Authorities SAMED appreciates other initiatives taken by the DoH in preparation for Medical Device regulation (Regulatory Institute) SAMED requests the DoH to recognise and engage with associations representing the Medical Devices Industry SAMED requests the DoH to pronounce on removal process requirements for Combination MD s currently registered as Medicines SAMED recommends a phased Risk Based approach to Medical Device regulations that will not be disruptive to continued provision of MD s

THANK YOU Medical device? 27